Use of oral antibiotics in protected units environment: clinical effectiveness and role in the emergence of antibiotic-resistant strains.
D000284:Administration, Oral; D000900:Anti-Bacterial Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D001414:Bacitracin / Q000627:therapeutic use; D004352:Drug Resistance, Microbial; D006801:Humans; D007165:Immunosuppression Therapy; D017053:Infection Control; D007612:Kanamycin / Q000627:therapeutic use; D007938:Leukemia / Q000150:complications*; D009355:Neomycin / Q000627:therapeutic use; D009761:Nystatin / Q000627:therapeutic use; D010357:Patient Isolators; D011113:Polymyxins / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D011113:Polymyxins; D009761:Nystatin; D001414:Bacitracin; D007612:Kanamycin; D009355:Neomycin